The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
Condition: Chronic RhinosinusitisInterventions: Drug: Mupirocin; Drug: PlaceboSponsor: University of MiamiActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2014 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin ointment; Drug: Mupirocin creamSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials